Physio-Assist

The Simeox system acquired by Inogen. [Image from Physio-Assist]Inogen (Nasdaq: INGN) announced today that it completed its previously announced acquisition of Physio-Assist.

Goleta, California-based Inogen announced its plan to acquire the French airway clearance technology developer in July. The deal includes a $32 million payment upfront and could reach up to $45 million in total.

Physio-Assist develops and manufactures its Simeox technology. Simeox, which currently has availability outside the U.S., is a technology-enabled airway clearance device. It treats bronchiectasis, where the lung’s bronchi become damaged and widened. It often occurs in cystic fibrosis and chronic obstructive pulmonary disease (COPD).

Pulmonary rehabilitation centers use Simeox, although it also offers in-home capabilities. The system has CE mark and other commercial availability in Asia and the Middle East. As a result of the closing of the deal, Inogen owns Physio-Assist now. I…

The Simeox system acquired by Inogen. [Image from Physio-Assist]Inogen (Nasdaq: INGN) announced today that it entered into a definitive agreement to acquire Physio-Assist.

Physio-Assist, a France-based, privately-held company develops and manufactures its Simeox technology. Simeox, which currently has availability outside the U.S., is a technology-enabled airway clearance device. It treats bronchiectasis, where the lung’s bronchi become damaged and widened. It often occurs in cystic fibrosis and chronic obstructive pulmonary disease (COPD).

Pulmonary rehabilitation centers use Simeox, although it also offers in-home capabilities. The system has CE mark and other commercial availability in Asia and the Middle East.

“This acquisition aligns with our strategy to diversify our portfolio to globally improve patient lives through respiratory care,” said Nabil Shabshab, Inogen president and CEO. “Simeox imminently expands our product offering in EMEA, and po…